Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art

Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art

Saved in:

Bibliographic Details
Main Authors:	Sylvie Hermouet, Hans C. Hasselbalch, Vladan Čokić
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2015/964613
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Promising Findings in Myeloproliferative Neoplasms and AL Amyloidosis
by: Axel Rüfer
Published: (2022-10-01)

Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms
by: Fabrizio Vianello, et al.
Published: (2011-01-01)

JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms
by: Nabih Maslah, et al.
Published: (2025-07-01)

Characteristics of regional epidemiological indicators of chronic myeloproliferative neoplasms
by: O. Yu. Vinogradova, et al.
Published: (2025-05-01)

Efficacy of JAK1/2 inhibition in murine myeloproliferative neoplasms is not mediated by targeting oncogenic signaling
by: Sivahari Prasad Gorantla, et al.
Published: (2025-05-01)

HMGB1 as a biomarker for myeloproliferative neoplasm complicated with atherosclerosis
by: Lunbi Wu, et al.
Published: (2025-05-01)

A Case of Myeloproliferative Neoplasm with Eosinophilia Associated with PCM1-JAK2 Rearrangement
by: Wen Zhou, et al.
Published: (2025-01-01)

Application of heteroduplex analysis for CALR mutation screening detection in patients with Ph-myeloproliferative neoplasms
by: T. N. Subbotina, et al.
Published: (2021-06-01)

Prevalence and clinical significance of sarcopenia in patients with chronic myeloproliferative neoplasms: epidemiology, diagnosis, and intervention strategies
by: Adelina G. Garifullina, et al.
Published: (2025-01-01)

USP5 inhibition via bone marrow-targeted engineered exosomes for myeloproliferative neoplasms therapy
by: Wenjun Wang, et al.
Published: (2025-07-01)

Pathways to myeloproliferative neoplasm presentation and time to diagnosis: results from a cross-sectional study
by: Emma-Louise Tarburn, et al.
Published: (2025-04-01)

Genomic profile helps to predict the clonal evolution and outcome of BCR-ABL-negative myeloproliferative neoplasms
by: Xiaodong Guo, et al.
Published: (2025-08-01)

PO09 | Comparison of different aggregometry methods for evaluation of platelet function in patients with myeloproliferative neoplasms
Published: (2025-08-01)

Clinicopathological spectrum of BCR-ABL-Negative myeloproliferative neoplasms with correlation with janus-associated kinase 2 mutation
by: Roopa Dixith, et al.
Published: (2019-01-01)

A Case of Myeloproliferative Neoplasm with BCR-FGFR1 Rearrangement: Favorable Outcome after Haploidentical Allogeneic Transplantation
by: Paola Villafuerte-Gutiérrez, et al.
Published: (2018-01-01)

PO35 | Cerebral veins thrombosis in patients with and without myeloproliferative neoplasm: a real life retrospective monocentric study
Published: (2025-08-01)

WCN24-2220 A DOUBLE HIT: CASE OF THROMBOTIC MICROANGIOPATHY CONCURRENT WITH MEMBRANOUS NEPHROPATHY IN A PATIENT WITH MYELOPROLIFERATIVE NEOPLASM
by: Yuliya Sharakova
Published: (2024-04-01)

Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome—insights from a UK center
by: Giulia Simini, et al.
Published: (2025-07-01)

Case Report: A novel t(15;17)(q24;q11.2) translocation involving NF1::SCAMP5 fusion in a patient with myeloproliferative neoplasms
by: Yuying Chang, et al.
Published: (2025-07-01)

ROLE OF SERUM EOSINOPHILIC CATIONIC PROTEIN AND TRYPTASE IN MYELOPROLIFERATIVE AND LYMPHOPROLIFERATIVE DISORDERS
by: L. S. Komarova, et al.
Published: (2014-07-01)

Comparison of molecular genetic methods of detection of mutations in the CALR gene in myeloproliferative disorders
by: L. A. Kesaeva, et al.
Published: (2019-07-01)

SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2
by: Hyun-Ju Cho, et al.
Published: (2025-07-01)

Expression of the BCR-ABL1 Gene in Patients with Chronic Myeloproliferative Diseases with Signs of Progression
by: LA Kesaeva, et al.
Published: (2018-10-01)

Chronic Kidney Disease and Malignant Neoplasms: The Current State of the Problem
by: I. T. Murkamilov, et al.
Published: (2022-03-01)

Natriuretic peptides as novel regulators of dendritic cells-mediated inflammation
by: Giorgia Manni, et al.
Published: (2025-07-01)

Chronic basophilic leukemia; A rare myeloproliferative disorder and the role of flow cytometry for its diagnosis
by: Saeid Anvari, et al.
Published: (2025-03-01)

Prevention of malignant neoplasms
by: D. G. Zaridze, et al.
Published: (2017-07-01)

DIAGNOSIS OF CHIASMAL NEOPLASMS
by: M. A. Kutin, et al.
Published: (2015-04-01)

PO42 | Acquired Von Willebrad syndrome in patients with myeloproliferative syndrome: literature review and single-center experience
Published: (2025-08-01)

Biologic agents in immune-mediated inflammatory rheumatic diseases: current state of the art and clinical practice in Romania
by: A. Balanesc, et al.
Published: (2017-09-01)

NEW APPROACHES TO THERAPY OF CLASSICAL PH-NEGATIVE MYELOPROLIFERATIVE DISEASES: THE EXPERIENCE OF EARLY THERAPY WITH CEPEGINTERFERON ALPHA-2B
by: A. S. Polyakov, et al.
Published: (2018-05-01)

Fetal treatment of sacrococcygeal teratoma: state of the art
by: M. C. Cianci, et al.
Published: (2025-06-01)

RENAL DAMAGE WITH MALIGNANT NEOPLASMS
by: I. B. Kolina, et al.
Published: (2015-01-01)

Scleroderma systematica concurrent with neoplasm
by: Maya Nikolayevna Starovoitova, et al.
Published: (2011-06-01)

Lipid Mediators in Skin Inflammation: Updates and Current Views
by: Giuseppe Valacchi, et al.
Published: (2010-01-01)

Inflammation mediated glycolipid dysregulation in coronary microvascular disease pathogenesis
by: Wei Wen, et al.
Published: (2025-07-01)

FEATURES OF CYTOKINE-MEDIATED REGULATION OF FOCAL AND SYSTEMIC INFLAMMATION IN COPD
by: E. A. Surkova, et al.
Published: (2014-07-01)

Cerebellar cryptococcoma simulating metastatic neoplasm
by: Hélio A.G. Teive, et al.
Published: (2009-09-01)

Features of the microbiota for various malignant neoplasms
by: L. G. Solenova, et al.
Published: (2024-09-01)

Descriptive characteristics of gynecological malignant neoplasms
by: A. V. Rumyantseva, et al.
Published: (2021-10-01)